Medtronic inks exclusive deal to sell Kuros bone graft device
In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
Kuros Biosciences AG / Key word (s): Agreement Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division 07-Jan-2025 / 07:00 CET/CEST Release of an ad ...
MassDevice2d
Medtronic spinal division inks agreement with Kuros Biosciences
Kuros Biosciences USA's strategic, exclusive sales agency agreement with Medtronic could boost adoption of its MagnetOs bone ...
Becker's Spine Review3d
Medtronic inks partnership for spinal biologics
Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.
Becker's Spine Review2d
4 medtech notes: Medtronic, Stryker and more
From new partnerships to acquisitions, here are four key developments from spine and orthopedic medtech companies since Jan. 1.
EurekAlert!10d
Custom-fit bone grafts: the future of craniomaxillofacial surgery
A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized ...
Science Daily10d
Achieving bone regeneration and adhesion with harmless visible light
A team develops an innovative injectable hydrogel for bone regeneration, addressing the limitations of traditional bone grafts and adhesion methods.
Kuros Biosciences AG: Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeriesKuros will work collaboratively to sel ...